Галина Белик

Галина Белик

Auto-generated profile, based on publicly available information

Галина Белик

Національний фармацевтичний університет, Харків, Україна

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 April 2021 in Ukrainian biopharmaceutical journal
Verified
Journal Article
Open access
PDF file
КЩК. Г. Щекіна
К. Г. Щекіна
GBG. Belik
G. Belik
DSD. Semeniv
D. Semeniv
VUV. Ulanova
V. Ulanova
Topicality. Recently, more and more works on the hepatotoxicity of NSAIDs have appeared in the literature. Presumably, all NSAIDs have hepatotoxicity, but the degree of adverse effects on the liver in different drugs is variable. Aim. To study the effect of different generations of NSAIDs on the functional state of the liver of the experimental animals. Materials and methods. Diclofenac sodium, piroxicam, indomethacin, meloxicam and celecocosib were selected for the comparative study. Changes in the functional state of the liver of intact rats during subchronic administration of the drugs selected, as well as their impact on the course of the model hepatitis were determined. The state of the liver was determined by the following indicators: the mass coefficient of the liver, the activity of alanine aminotransferase, alkaline phosphatase, the content of total protein, urea, cholesterol in the blood serum, the level of TBA-active products, diene conjugates, reduced glutathione, catalase and glycogen in the liver homogenate. Results and discussion. It was found that diclofenac, piroxicam, indomethacin in the doses of ED50 by the antiexudative activity when used for 14 days adversely affected the liver of intact animals, as well as worsened the course of the model hepatitis, i.e. had a pronounced hepatotoxic effect. Meloxicam and celecoxib did not show a pronounced adverse effect in the carbon tetrachloride hepatitis, but contributed to the deterioration of the functional state of the liver of intact rats, i.e. had a moderate hepatotoxic effect. Conclusions. By the level of hepatotoxicity the drugs studied can be arranged as follows: diclofenac > indomethacin > piroxicam > meloxicam > celecoxib.

14 September 2017 in Clinical pharmacy
Verified
Journal Article
Open access
PDF file
CSC. G. Shchokina
C. G. Shchokina
GBG. V. Belik
G. V. Belik
TKT. O. Kutsenko
T. O. Kutsenko
DSD. V. Semeniv
D. V. Semeniv
Benign prostatic hyperplasia (BPHP) is one of the most common diseases in middle-aged and elderly men. In this regard, the search and study of new effective and safe medicines with the prostatoprotective effect is important and topical. For today, the nomenclature of domestic protostatotectors of the plant origin is limited. Aim. To study experimentally the protoprotective properties of thick extracts of roots and leaves of common burdock on the model of sulpiride-induced prostatic hyperplasia in rats. Materials and methods. The BPHP model reproduced the intraperitoneal administration of sulpiride to male rats in the dose of 40 mg/kg for 30 days. Thick burdock extracts in the dose of 75 mg/kg and the reference drug Prostaplant Forte in the dose of 35 mg/kg were administered intraperitoneally in the therapeutic regimen from day 31 to day 52 of the study. Results. It has been proven that thick extracts of roots and leaves of burdock on the model of sulpiride-induced benign prostatic hyperplasia in rats reduce development of inflammatory processes, inhibit the processes of LPO, normalize the antioxidant / prooxidant balance in the animal’s body. Under the influence of these extracts the level of androgenic saturation of the body and the testosterone/estradiol ratio increase, indicating a positive effect of drugs on spermatogenesis. Thick extracts of burdock roots and leaves reduce the level of estradiol and dihydrotestosterone in the blood serum of the experimental animals, and it impedes development of proliferative processes in the prostate and inhibits development of the disease. Conclusions. By the intensity of the prostatoprotective action thick extracts of roots and leaves of common burdock are not inferior to the reference drug Prostaplant Forte.

30 December 2021 in ScienceRise: Biological Science
Verified
Journal Article
Open access
PDF file
TKTetiana Kutsenko
Tetiana Kutsenko
DSDmitro Semeniv
Dmitro Semeniv
KSKatherina Shchokina
Katherina Shchokina
GBGalina Belik
Galina Belik
YSYurii Stoletov
Yurii Stoletov
OGOlga Getalo
Olga Getalo
The aim. Determination of the need to raise awareness of the population about multivitamins and the criteria for their rational choice. Materials and research methods. To achieve the goal of the study, it was necessary to develop a questionnaire for visitors to pharmacies and carry out an anonymous survey of them. All adult visitors of the pharmacy were attracted to the survey. The developed questionnaire consisted of 3 parts and contained 32 questions processed in the course of our own research. Research results. Among the pharmacy visitors we surveyed, the majority were between the ages of 35–55, approximately equally divided were men and women who mainly lived in the Kiev region (87 %), were not students and did not have educational levels of bachelor or master, and had no relation in health care education. Summarizing the information obtained in the course of processing questionnaires with the answers of visitors to pharmacies, it can be noted that in the surveyed group of respondents there is a certain interest and indifference to the discussed aspects, but quite often there is a lack of knowledge in this regard. Conclusions. In the course of analyzing the results of the questionnaire survey, the level of awareness of the population regarding general information about the pharmacology of multivitamin drugs and the criteria for their correct choice was determined. From the data obtained, it can be concluded that on many issues the respondents showed an insufficient level of knowledge, which justifies the need for additional information about multivitamins, and indicates that better it should be done with participation of a specialist with a pharmaceutical education or physician. Mostly the population lacks knowledge on the issues listed in the second part of the questionnaire, namely, on general information about the biological and pharmacological properties of vitamins. It was found that the information obtained from the Internet or other media, including advertising, has a significant impact on the awareness and decision of the respondents

11 December 2020
Verified
Conference Paper
Open access
PDF file
НКНиколай Коваленко
Николай Коваленко
ГБГалина Белик
Галина Белик
ТКТатьяна Куценко
Татьяна Куценко
ВУВера Уланова
Вера Уланова
ЮСЮрий Столетов
Юрий Столетов


29 March 2024 in Likars'ka Sprava
Verified
Journal Article
Open access
PDF file
SDS. M. Drohovoz
S. M. Drohovoz
YBYa. O. Butko
Ya. O. Butko
MBM. M. Babenko
M. M. Babenko
LDL. V. Derymedvid
L. V. Derymedvid
NMN. O. Melenchenko
N. O. Melenchenko
GBG. V. Belik
G. V. Belik
Вітамінні препарати є популярними препаратами серед населення, однак, їх безконтрольне вживання впливає на безпеку вітамінотерапії. Сучасні підходи до безпеки ліків в Україні передбачають збір інформації про їх побічні реакції (ПР) завдяки повідомленням при проведенні клінічних випробувань та результатам моніторингу ПР при медичному застосуванні препаратів. Тому, щорічний аналіз даних фармаконагляду щодо випадків виникнення ПР при здійсненні вітамінотерапії та оцінці їхньої безпеки є актуальним. Метою дослідження став аналіз частоти виникнення ПР при застосуванні вітамінних препаратів у Харківському регіоні. У результаті проведеного аналізу встановлено, що у медичних установ Харківського регіону зареєстровані повідомлення про ПР при застосуванні вітамінних препаратів: за період 2020-2021 рр. у середньому надійшло 3,1 % повідомлень від загальної кількості випадків ПР на препарати. Найбільше їх зареєстровано при застосуванні вітамінів групи В – 77,2 % повідомлень. З них найбільша кількість повідомлень надійшла на препарати ВІТАКСОН (10,2 %), НІКОТИНОВА КИСЛОТА та ПІРИДОКСИНУ ГІДРОХЛОРИД (по 8,5 %). ПР препаратів вітамінів проявлялись переважно у вигляді місцевих ПР: свербіж (23,7 %), висипи на тілі (21,1 %), гіперемія шкіри (10,5 %), висипи по типу кропивниці (5,3 %), гіперемія обличчя та набряки у місці введення (по 3,5 %). Для ПІРИДОКСИНУ ГІДРОХЛОРИД був зареєстрований випадок анафілактичного шоку, який потребував невідкладної медичної допомоги. Перелічені ПР внесені до інструкції для медичного застосування вітамінів, тобто є передбачуваними. Отримані результати можуть бути використані представниками МОЗ України, які займаються аналізом фармаконагляду, з метою пошуку заходів у зменшені та усунення ПР при застосуванні вітамінотерапії в різних областях медицини.